Article
[A20 haploinsufficiency: what do clinicians need to know?]
La Revue de medecine interne - 1 Jul 2024
Elhani I, Aouba A, Riller Q, Vergneault H, Boursier G, Rieux-Laucat F, Hentgen V, Georgin-Lavialle S
Abstract excerpt
A20 Haploinsufficiency (HA20) is a monogenic autoinflammatory disease associated with an autosomal dominant mutation in the TNFAIP3 gene. It induces a defect in the inactivation of the pro-inflammatory NF-κB pathway. Less than 200 cases have been described worldwide. The clinical picture of the disease is essentially based on the association of recurrent fever and/or biologic inflammatory syndrome, aphtosis,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
